Herbal Synergy Decoded: Single-Cell Analysis Reveals How a Classic Chinese Medicine Formula Heals the Infracted Heart
en-GBde-DEes-ESfr-FR

Herbal Synergy Decoded: Single-Cell Analysis Reveals How a Classic Chinese Medicine Formula Heals the Infracted Heart

19/11/2026 HEP Journals

Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Coronary artery occlusion triggers a cascade of pathological events — myocardial injury, oxidative stress, excessive inflammation, massive cardiomyocyte apoptosis, impaired vascular endothelial function, and fibrosis. Despite advances in revascularization strategies such as percutaneous coronary intervention, and the use of single-target drugs like β-blockers and ACE inhibitors, post-AMI heart failure and mortality rates remain elevated, highlighting the urgent need for therapies capable of simultaneously modulating multiple pathological pathways.
The Shenqi Fuzheng (SQ) formula is a classic herbal combination in Traditional Chinese Medicine (TCM), prepared from Codonopsis Radix (Dangshen, DS) and Astragali Radix (Huangqi, HQ). Guided by TCM theory, it is traditionally used to supplement qi and strengthen vital qi. Clinically, SQ has long been used as a well-tolerated adjuvant therapy with documented benefits in cardiovascular diseases, including improved cardiac function in patients with heart failure after AMI. However, two key questions remained unanswered: does combining DS and HQ truly produce synergistic effects, and what molecular and cellular programs underlie this therapeutic synergy?
In a study published in Chinese Journal of Natural Medicines, researchers from Zhejiang University and collaborating institutions addressed both questions through an integrated strategy combining chemical profiling, network pharmacology, RNA sequencing (RNA-seq), and single-cell RNA sequencing (scRNA-seq) of AMI rat hearts.
First, UPLC-Triple-TOF/MS analysis identified 24 compounds in DS and 55 in HQ — DS being mainly composed of alkaloids and alkyl polyglucosides, while HQ primarily contains flavonoids and terpenoids such as astragaloside IV. In the AMI rat model, combination index calculations using the Bliss independence and Highest Single Agent models confirmed genuine synergy: SQ reduced infarct size and improved left ventricular ejection fraction and fractional shortening more effectively than either herb alone (CI values consistently below 1).
Network-level analysis revealed why. SQ restored the expression of 77.49% (1,043 of 1,346) of genes dysregulated in the AMI disease network — far exceeding DS (43.91%) or HQ (49.26%) monotherapy — with co-regulated targets including Edn1, Enpp1, F3, and Vegfr1 implicated in oxidative stress regulation, coagulation, and angiogenesis.
To pinpoint the cellular basis of this synergy, the team performed scRNA-seq on 55,839 non-cardiomyocyte cells from treated hearts. Macrophages and monocytes, endothelial cells, and fibroblasts showed the most pronounced changes after AMI. Notably, endothelial cell counts increased only with co-administration, not with monotherapy. Sub-clustering identified a post-infarction endothelial subset (Endo 1) associated with mesenchymal activation and newborn microvessels in the border zone; combination treatment drove the strongest pro-angiogenic response in this population, with 415 differentially expressed genes enriched in vasculature development and cell migration pathways — and a higher microvessel density in the infarct border zone confirmed by CD31 immunofluorescence.
On the immune side, the combination expanded a Trem2/Spp1/Gpnmb/Fabp5-enriched reparative macrophage subset (Mac 2) with anti-inflammatory and pro-angiogenic features, increased Arg1 expression, and reduced NO production in LPS/IFN-γ-stimulated macrophages — with the strongest effects under co-treatment. Cell-cell communication analysis using CellChat showed that Mac 2–Endo 1 interactions and VEGFA-related ligand-receptor signaling were most enhanced by the combination, supported by increased CD68⁺TREM2⁺VEGFA⁺ macrophages and VEGFA secretion in vitro. Molecular docking suggested that representative compounds from both herbs bind distinct sites on VEGFA, and crucially, pharmacological inhibition of VEGFR signaling with Lenvatinib attenuated the pro-angiogenic effect of SQ treatment — confirming the involvement of the VEGFA-VEGFR pathway.
Together, these findings reveal a dual mechanism of herbal synergy: combination treatment not only directly promotes endothelial microvascular formation but also enhances the anti-inflammatory and pro-angiogenic capacities of a reparative macrophage subset, indirectly promoting angiogenesis through macrophage-endothelial crosstalk. This coordinated regulation provides a plausible mechanistic explanation for the reduced infarct size and improved cardiac outcomes seen in vivo — and offers scientific evidence for the synergistic use of TCM herb pairs, while demonstrating the power of single-cell approaches in modernizing research on traditional compound formulas.
The work entitled “Single-cell analysis reveals synergistic therapeutic mechanisms of Shenqi Fuzheng formula against acute myocardial infarction” was published in Chinese Journal of Natural Medicines (published in October, 2026).
DOI: 10.1016/S1875-5364(26)61214-9
Attached files
  • Image: Combination treatment promotes angiogenesis in endothelial cell subsets and their crosstalk.
19/11/2026 HEP Journals
Regions: Asia, China
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by AlphaGalileo Terms Of Use Privacy Statement